Organon Stock Forecast
NYSE: OGNHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
OGN analyst consensus
Consensus (4 analysts)
none
Avg. price target
$10.33-25.63%
- Strong buy 0
- Buy 0
- Hold 3
- Sell 0
- Strong sell 1
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
What analysts say
According to 4 Wall Street analysts covering Organon (2026-11-19), 0 rate the stock a buy or strong buy, 3 rate it a hold and 1 rate it a sell or strong sell, for a consensus rating of "none". The average 12-month price target is $10.33, with a high estimate of $14.00 and a low estimate of $8.00. The average target implies downside of 25.6% from the current price of $13.89.
The spread between the highest and lowest targets is 75.0%, a relatively narrow range. Price targets and ratings are the opinions of third-party analysts, not MetaCap. They are frequently revised and have a mixed track record, so treat them as one input among many for OGN.
Summary generated from market data by MetaCap's automated system. Methodology
Rating distribution
| Rating | Analysts | Share |
|---|---|---|
| Strong buy | 0 | 0% |
| Buy | 0 | 0% |
| Hold | 3 | 75% |
| Sell | 0 | 0% |
| Strong sell | 1 | 25% |
Ratings as of 2026-11-19.
Price target scenarios
| Target | Price | vs. current |
|---|---|---|
| Low target | $8.00 | -42.40% |
| Average target | $10.33 | -25.63% |
| High target | $14.00 | +0.79% |